Crossmark

Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s00228-024-03779-2

Published Online: 2024-11-23

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mitsuboshi, Satoru https://orcid.org/0000-0002-6244-1253
Hitoshi, Kotaro

Ominato, Ai

Kinoshita, Teruhisa

Sugimoto, Yuka

Kajiwara-Morita, Ayami

Urata, Motoki

Sato, Koji

Sakamaki, Toshiyuki
Funding

Funding for this research was provided by:

Niigata University of Pharmacy and Applied Life Sciences
License Information

Text and Data Mining valid from 2024-11-23

Version of Record valid from 2024-11-23
More Information

Article History

Received: 27 June 2024

Accepted: 15 November 2024

First Online: 23 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below